Work

Radotinib is an effective inhibitor of native and kinase domain-mutant BCR-ABL1

Year: 2015

Type: article

Source: Leukemia

DOI: 10.1038/leu.2015.42

Authors: M S Zabriskie, N A Vellore, K C Gantz, M W Deininger, T O'Hare

Institutions: Huntsman Cancer Institute, University of Utah

Language: English

Topic: Chronic Myeloid Leukemia Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funder: National Cancer Institute

Award: G368171078

OpenAlex ID: W2039697666

FWCI: 3.629

Cites: 15

Cited by: 48

Related to: 10